Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Aug 9;39(8):1031-1033.
doi: 10.1016/j.ccell.2021.07.012. Epub 2021 Jul 22.

Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies

Lee M Greenberger  1 , Larry A Saltzman  2 , Jonathon W Senefeld  3 , Patrick W Johnson  4 , Louis J DeGennaro  2 , Gwen L Nichols  2
Affiliations
Comment

Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies

Lee M Greenberger et al. Cancer Cell. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

Comment in

  • Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer.
    Mairhofer M, Kausche L, Kaltenbrunner S, Ghanem R, Stegemann M, Klein K, Pammer M, Rauscher I, Salzer HJF, Doppler S, Habringer A, Paar C, Kimeswenger S, Hoetzenecker W, Lamprecht B, Lee S, Schmitt CA. Mairhofer M, et al. Cancer Cell. 2021 Sep 13;39(9):1171-1172. doi: 10.1016/j.ccell.2021.08.001. Epub 2021 Aug 17. Cancer Cell. 2021. PMID: 34450047 Free PMC article. No abstract available.

Comment on

References

    1. Boyarsky B.J., Werbel W.A., Avery R.K., Tobian A.A.R., Massie A.B., Segev D.L., Garonzik-Wang J.M. Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine series in solid organ transplant recipients. JAMA. 2021;325:1784–1786. doi: 10.1001/jama.2021.4385. - DOI - PMC - PubMed
    1. Creech C.B., Walker S.C., Samuels R.J. SARS-CoV-2 vaccines. JAMA. 2021;325:1318–1320. doi: 10.1001/jama.2021.3199. - DOI - PubMed
    1. FDA EUA authorized serology test performance. 2020. https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-em... Accessed April 12, 2021.
    1. Griffiths E.A., Segal B.H. Immune responses to COVID-19 vaccines in patients with cancer: promising results and a note of caution. Cancer Cell. 2021;39:1045–1047. doi: 10.1016/j.ccell.2021.07.001. - DOI - PMC - PubMed
    1. Herishanu Y., Avivi I., Aharon A., Shefer G., Levi S., Bronstein Y., Morales M., Ziv T., Shorer Arbel Y., Scarfò L., et al. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Blood. 2021;137:3165–3173. doi: 10.1182/blood.2021011568. Published online April 16, 2021. - DOI - PMC - PubMed

Substances